FN America recently discovered a condition on the FN Reflex MRD pistol that, in very limited circumstances when using the incorrect set of screws to mount specific optics, the pistol could ...

At a time when the EU is engaged in a rearmament race and looking to build up its defence industry, the Belgian arms manufacturer is taking advantage of member states' interest in security issues.

Addition of TUS to standard of care VEN+AZA creates a well-tolerated and mutation agnostic frontline triple drug therapy for newly diagnosed AML Addition of TUS to standard of care VEN+AZA creates ...

BioNTech kauft CureVac für $1,25 Mrd., stärkt Onkologiegeschäft Unternehmen befanden sich im Wettlauf um Corona-Impfstoff Deal vereint komplementäre Kompetenzen im Krebs-Bereich ...

Adaptive Biotechnologies Corporation announced that its clonoSEQ® test for measurable residual disease (MRD) will be prominently featured in 30 presentations at the upcoming American Society of ...

DVRd therapy significantly improves MRD negativity and PFS, showing potential as a frontline treatment for NDMM patients who are transplant-ineligible or deferred. The CEPHEUS trial highlights ...

The new collaborations with Tracer Biotechnologies and Foresight Diagnostics expand QIAGEN’s reach in MRD testing and cover solid tumors and hematological cancers. Minimal residual disease (MRD ...

Barclays analyst George Wang recently lowered the price target on Fabrinet (NYSE:FN) to $234 from $245 and kept an Equal Weight rating on the shares. Fabrinet offers optical packaging, along with ...

The oral presentation at EHA included updated safety, complete remission, minimal residual disease (MRD) assessments, and longer duration of follow-up: Title: TUSCANY Study of Safety and Efficacy of ...

SAN DIEGO and TORONTO, June 12, 2025 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (TSX: APS; OTC: APTOF), a clinical-stage precision oncology company, today ...

This collaboration aims to deliver highly sensitive, cost-effective, and decentralized MRD testing solutions that enable oncologists to monitor cancer recurrence and guide personalized treatment ...